Dexcom G7 Now Connects to the Tandem t:slim X2 Insulin Pump

Dexcom G7 users can also share glucose data with loved ones and care teams.

Mark Andrews Dexcom G7 Tandem

DexCom, a provider of real-time continuous glucose monitoring for people with diabetes, announced today the Dexcom G7 Continuous Glucose Monitoring (CGM) System now connects with the t:slim X2 insulin pump by Tandem Diabetes Care in the United States, marking the first AID integration with the Dexcom G7 CGM.

“There’s a reason Dexcom is the undisputed leader in CGM connectivity and the clear choice for AID systems,” said Jake Leach, executive vice president and chief operating officer at Dexcom. “We pioneered industry-leading CGM connectivity more than a decade ago and are the only CGM company to have safely powered AID systems for more than 1 million patient years of cumulative use. The clinically meaningful health outcomes that result from using the t:slim X2 insulin pump with Control-IQ technology are proven only when the system is connected to Dexcom CGM technology.”

Further solidifying Dexcom as the most studied CGM brand with AID capabilities, new results from the COMISAIR seven-year follow up – the longest prospective real-world CGM study ever conducted – showed significant and continued reduction of HbA1c as well as a lower risk of the development or progression of diabetic retinopathy associated with the use of real-time CGM by people with Type 1 diabetes. Additionally, the COMISAIR seven-year follow up demonstrated further substantial reduction in HbA1c when Dexcom CGM is connected to the Tandem t:slim X2 insulin pump with Control-IQ technology. 

“When AID systems are used in conjunction with real-time CGM, people with diabetes experience more time in range, fewer incidences of hypoglycemia and greater peace of mind,” said Dr. Nicholas Argento, MD FACE. “As both a user and prescriber of these connected systems, I’ve seen the positive impacts this technology has on the health and overall wellbeing of people managing diabetes, which is reaffirmed by a growing body of clinical evidence.”

Dexcom G7 is the smallest CGM system currently connected to the t:slim X2 insulin pump. It is also the fastest CGM connected to the t:slim X2 pump with a 30-minute sensor warmup, and along with Dexcom G6, are the only CGM systems with a predictive urgent low soon alert and no fingersticks required from day one. Dexcom G7 users can also share glucose data with loved ones and care teams in real time through industry-leading remote monitoring capabilities.

Tandem will email instructions to all in-warranty t:slim X2 users in the United States to offer the option to add the new feature free of charge via remote software update. Tandem t:slim X2 pumps pre-loaded with Dexcom G7 integration are now shipping to new customers. Starting today, Dexcom G7 sensors compatible with the t:slim X2 pump are available through Durable Medical Equipment (DME) distributors, with pharmacy availability launching in early January 2024.

More in Devices